CareCloud Highlights Successful Preferred A Conversion, Progress Toward Capital Structure Simplification, and Reaffirms Growth Outlook
MWN-AI** Summary
CareCloud, Inc. has successfully completed the conversion of its Series A Preferred Stock (formerly CCLDP) into common equity, marking a significant step toward simplifying its capital structure. As of the conversion on March 6, 2025, CareCloud issued approximately 26 million shares of common stock, raising the total shares outstanding to around 42 million. This strategic move has been well absorbed by the market, with the stock trading consistently, reflected in a recent closing price of $3.49 as of March 27, 2026. Only three major shareholders remain with substantial holdings of the Preferred A shares, indicating a smooth transition that underscores the strength of CareCloud's business model and its recurring revenue streams.
CEO Stephen Snyder emphasized the company's focus on simplifying its capital structure further, noting that there is about $40 million of Series B Preferred Stock outstanding, which does not have a conversion feature and thus will not dilute existing common shareholders. CareCloud reaffirmed its previous financial guidance and expressed confidence in maintaining its growth trajectory despite a recent cybersecurity incident that was contained without significant operational impact.
CareCloud continues to deliver innovative healthcare technology solutions, focusing on enhancing operational efficiency and improving patient experiences for over 45,000 providers. The company's commitment to advancing its capital structure initiatives while fostering growth demonstrates its dedication to creating value for shareholders and improving healthcare delivery.
For more information on CareCloud's offerings and corporate updates, visit carecloud.com or explore their investor relations platform.
MWN-AI** Analysis
CareCloud, Inc.’s recent conversion of its Series A Preferred Stock into common equity marks a significant milestone in its transition towards a more streamlined capital structure. With around 26 million new shares issued, the company’s total outstanding shares have increased to approximately 42 million. This development, completed on March 6, 2025, suggests robust market absorption, as the stock price has demonstrated resilience, hovering around $3.49 as of March 27, 2026.
For investors, this successful conversion is a positive indicator that the market perceives CareCloud's underlying business fundamentals as strong. The company has reaffirmed its financial guidance and growth outlook, signaling confidence in its ability to navigate challenges and capitalize on opportunities in the healthcare technology sector. Importantly, the only remaining Series B Preferred Stock, which does not feature a conversion into common equity, should alleviate concerns regarding further dilution for common shareholders. This aspect alone makes CareCloud an attractive consideration for investors looking to minimize exposure to equity dilution while still gaining from future growth.
Moreover, CareCloud’s commitment to simplifying its capital structure and enhancing its operational efficiency bodes well for long-term value creation. The reported strong recurring revenue and cash flow generation support its initiatives and offer a strong foundation for sustainable growth. It is also worth noting the containment of a recent cybersecurity incident which the company claims has had no significant operational impact, further emphasizing management's ability to respond effectively to potential risks.
Overall, given CareCloud’s growth trajectory and strategic initiatives, investors may find it prudent to consider entering or expanding positions in CCLD, particularly as the company continues to innovate and strengthen its market position in healthcare technology.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
SOMERSET, N.J., March 30, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of healthcare technology and revenue cycle management solutions, today highlighted the successful continued market absorption of the Q1 2025 conversion of its Series A Preferred Stock (“Preferred A”, formerly traded as CCLDP) into common equity, while reaffirming its previously issued financial guidance and continued confidence in its growth outlook.
The Preferred A conversion, completed on March 6, 2025, resulted in the issuance of approximately 26 million shares of common stock, increasing CareCloud’s total common shares outstanding from approximately 16 million shares to approximately 42 million shares. Since the completion of the conversion, the Company’s stock has demonstrated resilience and continues to trade in line with levels observed prior to and during the conversion period, with a recent closing price of $3.49 on March 27, 2026. The conversion of Preferred A has been substantially completed, with only three substantial shareholders remaining. The Company believes this orderly market transition reflects the underlying strength of its business fundamentals and recurring revenue model.
“Supported by its strong operating model, including significant recurring revenue and robust cash flow generation, CareCloud intends to further simplify its capital structure over time,” said Stephen Snyder, Chief Executive Officer of CareCloud. “The Company currently has approximately $40 million of Series B Preferred Stock outstanding, which, unlike Preferred A, does not have a conversion feature into common equity and therefore does not represent a source of future dilution to CCLD shareholders.”
The Company also reaffirms its previously issued financial guidance and remains confident in its outlook for continued growth, with the previously disclosed cybersecurity incident, which was promptly contained and limited to one of the Company’s six EHR environments, and believed to have no material impact on operations. The Company appreciates the continued support of its shareholders as it advances its capital structure initiatives.
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows, and improve the patient experience. More than 45,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases, and view the latest investor presentation, please visit ir.carecloud.com.
Disclaimer
This press release is for informational purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management’s expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not undertake any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE: CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
FAQ**
How has the conversion of CareCloud Inc. 1Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP impacted the overall capital structure and market perception of CareCloud since the transition was completed in March 2025?
What specific strategies does CareCloud plan to implement to simplify its capital structure beyond the conversion of CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP, especially with the remaining Series B Preferred Stock?
Given the historical performance of CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP, how does the company anticipate future growth potential influenced by its recurring revenue model?
In light of the recent cybersecurity incident, how has CareCloud's management ensured the continued confidence of investors in the aftermath of the conversion of CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP?
**MWN-AI FAQ is based on asking OpenAI questions about CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock (NASDAQ: CCLDP).
NASDAQ: CCLDP
CCLDP Trading
-10.6% G/L:
$19.43 Last:
23,210 Volume:
$21.49 Open:
